Andrew Penn, RN, MS, NP, CNS, APRN-BC
Clinical Professor
University of California, San Francisco, School of Nursing
University of California, San Francisco
San Francisco, California
Lynn Marie Morski, MD, JD
President
Psychedelic Medicine Association
San Diego, California
.jpg "Stephen Xenakis, MD photo")
Stephen Xenakis, MD
Executive Director
American Psychedelic Practitioners Association
Uniformed University of Health Sciences
Hallandale Beach, Florida
Karen Cooper, RN, BSN, MA
Clinical Consultant, Mentor, Advisor, Guide
Psychedelic Therapies
Research and Education
San Franciso, California
This panel discussion will highlight the different missions, resources, and programs available from the Psychedelic Medicine Association (PMA), American Psychedelic Practitioners Association (APPA), and California Institute of Integral Studies (CIIS) and how they all fit into the larger framework of establishing safeguards for the integration of psychedelic medicine into the mainstream medical world. The PMA helps expand practitioner knowledge and awareness of psychedelics and helps practitioners feel more comfortable and confident discussing psychedelic therapies with patients and referring patients to those therapies, while APPA is working to make sure there are safe and regulated places for practitioners to refer patients that are interested and good candidates for this type of treatment. CIIS provides training opportunities for both licensed medical prescribers or therapists and facilitators who are not licensed but who may do this work legally per state law.